Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981036651> ?p ?o ?g. }
- W1981036651 endingPage "2267" @default.
- W1981036651 startingPage "2259" @default.
- W1981036651 abstract "Heart failure (HF) developing in hypertensive patients may occur with preserved or reduced left ventricular ejection fraction (PEF [>or=50%] or REF [<50%]). In the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), 42 418 high-risk hypertensive patients were randomized to chlorthalidone, amlodipine, lisinopril, or doxazosin, providing an opportunity to compare these treatments with regard to occurrence of hospitalized HFPEF or HFREF.HF diagnostic criteria were prespecified in the ALLHAT protocol. EF estimated by contrast ventriculography, echocardiography, or radionuclide study was available in 910 of 1367 patients (66.6%) with hospitalized events meeting ALLHAT criteria. Cox regression models adjusted for baseline characteristics were used to examine treatment differences for HF (overall and by PEF and REF). HF case fatality rates were examined. Of those with EF data, 44.4% had HFPEF and 55.6% had HFREF. Chlorthalidone reduced the risk of HFPEF compared with amlodipine, lisinopril, or doxazosin; the hazard ratios were 0.69 (95% confidence interval [CI], 0.53 to 0.91; P=0.009), 0.74 (95% CI, 0.56 to 0.97; P=0.032), and 0.53 (95% CI, 0.38 to 0.73; P<0.001), respectively. Chlorthalidone reduced the risk of HFREF compared with amlodipine or doxazosin; the hazard ratios were 0.74 (95% CI, 0.59 to 0.94; P=0.013) and 0.61 (95% CI, 0.47 to 0.79; P<0.001), respectively. Chlorthalidone was similar to lisinopril with regard to incidence of HFREF (hazard ratio, 1.07; 95% CI, 0.82 to 1.40; P=0.596). After HF onset, death occurred in 29.2% of participants (chlorthalidone/amlodipine/lisinopril) with new-onset HFPEF versus 41.9% in those with HFREF (P<0.001; median follow-up, 1.74 years); and in the chlorthalidone/doxazosin comparison that was terminated early, 20.0% of HFPEF and 26.0% of HFREF patients died (P=0.185; median follow-up, 1.55 years).In ALLHAT, with adjudicated outcomes, chlorthalidone significantly reduced the occurrence of new-onset hospitalized HFPEF and HFREF compared with amlodipine and doxazosin. Chlorthalidone also reduced the incidence of new-onset HFPEF compared with lisinopril. Among high-risk hypertensive men and women, HFPEF has a better prognosis than HFREF." @default.
- W1981036651 created "2016-06-24" @default.
- W1981036651 creator A5006628692 @default.
- W1981036651 creator A5010988550 @default.
- W1981036651 creator A5014889218 @default.
- W1981036651 creator A5026827724 @default.
- W1981036651 creator A5036729289 @default.
- W1981036651 creator A5040679539 @default.
- W1981036651 creator A5042299275 @default.
- W1981036651 creator A5059040148 @default.
- W1981036651 creator A5068557720 @default.
- W1981036651 creator A5074117194 @default.
- W1981036651 creator A5087570461 @default.
- W1981036651 date "2008-11-25" @default.
- W1981036651 modified "2023-10-15" @default.
- W1981036651 title "Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial" @default.
- W1981036651 cites W1547783254 @default.
- W1981036651 cites W1969921809 @default.
- W1981036651 cites W1971100497 @default.
- W1981036651 cites W1973388391 @default.
- W1981036651 cites W1975476355 @default.
- W1981036651 cites W1979384626 @default.
- W1981036651 cites W1981273540 @default.
- W1981036651 cites W2000701024 @default.
- W1981036651 cites W2000983589 @default.
- W1981036651 cites W2007946529 @default.
- W1981036651 cites W2015525328 @default.
- W1981036651 cites W2018763145 @default.
- W1981036651 cites W2047043096 @default.
- W1981036651 cites W2070746484 @default.
- W1981036651 cites W2076911162 @default.
- W1981036651 cites W2077842562 @default.
- W1981036651 cites W2086291738 @default.
- W1981036651 cites W2087109276 @default.
- W1981036651 cites W2092529874 @default.
- W1981036651 cites W2094410878 @default.
- W1981036651 cites W2094447403 @default.
- W1981036651 cites W2099156846 @default.
- W1981036651 cites W2106909429 @default.
- W1981036651 cites W2109281287 @default.
- W1981036651 cites W2117460265 @default.
- W1981036651 cites W2128929076 @default.
- W1981036651 cites W2133155835 @default.
- W1981036651 cites W2137784332 @default.
- W1981036651 cites W2140058582 @default.
- W1981036651 cites W2140444872 @default.
- W1981036651 cites W2145730124 @default.
- W1981036651 cites W2153783106 @default.
- W1981036651 cites W2166089332 @default.
- W1981036651 cites W2170881441 @default.
- W1981036651 cites W2323050154 @default.
- W1981036651 cites W2342114857 @default.
- W1981036651 cites W2562329777 @default.
- W1981036651 cites W27593660 @default.
- W1981036651 cites W4235435263 @default.
- W1981036651 cites W4238841221 @default.
- W1981036651 cites W4255009698 @default.
- W1981036651 cites W4296216349 @default.
- W1981036651 cites W4299689471 @default.
- W1981036651 doi "https://doi.org/10.1161/circulationaha.107.762229" @default.
- W1981036651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2775475" @default.
- W1981036651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19001024" @default.
- W1981036651 hasPublicationYear "2008" @default.
- W1981036651 type Work @default.
- W1981036651 sameAs 1981036651 @default.
- W1981036651 citedByCount "185" @default.
- W1981036651 countsByYear W19810366512012 @default.
- W1981036651 countsByYear W19810366512013 @default.
- W1981036651 countsByYear W19810366512014 @default.
- W1981036651 countsByYear W19810366512015 @default.
- W1981036651 countsByYear W19810366512016 @default.
- W1981036651 countsByYear W19810366512017 @default.
- W1981036651 countsByYear W19810366512018 @default.
- W1981036651 countsByYear W19810366512019 @default.
- W1981036651 countsByYear W19810366512020 @default.
- W1981036651 countsByYear W19810366512021 @default.
- W1981036651 countsByYear W19810366512022 @default.
- W1981036651 countsByYear W19810366512023 @default.
- W1981036651 crossrefType "journal-article" @default.
- W1981036651 hasAuthorship W1981036651A5006628692 @default.
- W1981036651 hasAuthorship W1981036651A5010988550 @default.
- W1981036651 hasAuthorship W1981036651A5014889218 @default.
- W1981036651 hasAuthorship W1981036651A5026827724 @default.
- W1981036651 hasAuthorship W1981036651A5036729289 @default.
- W1981036651 hasAuthorship W1981036651A5040679539 @default.
- W1981036651 hasAuthorship W1981036651A5042299275 @default.
- W1981036651 hasAuthorship W1981036651A5059040148 @default.
- W1981036651 hasAuthorship W1981036651A5068557720 @default.
- W1981036651 hasAuthorship W1981036651A5074117194 @default.
- W1981036651 hasAuthorship W1981036651A5087570461 @default.
- W1981036651 hasBestOaLocation W19810366511 @default.
- W1981036651 hasConcept C126322002 @default.
- W1981036651 hasConcept C164705383 @default.
- W1981036651 hasConcept C207103383 @default.
- W1981036651 hasConcept C27016395 @default.
- W1981036651 hasConcept C2777590997 @default.
- W1981036651 hasConcept C2777880890 @default.
- W1981036651 hasConcept C2778198053 @default.